Cancer Epidemiology Biomarkers and Prevention (CEBP) is a scholarly journal dedicated to publishing research in the field of Medicine. American Association for Cancer Research is the publisher of this esteemed journal. The P-ISSN assigned to Cancer Epidemiology Biomarkers and Prevention is 1055-9965 and its abbreviated form is Cancer Epidemiol Biomarkers Prev.
Cancer Epidemiology, Biomarkers & Prevention publishes original peer-reviewed, population-based research on cancer etiology, prevention, surveillance, and survivorship. The following topics are of special interest: descriptive, analytical, and molecular epidemiology; biomarkers including assay development, validation, and application; chemoprevention and other types of prevention research in the context of descriptive and observational studies; the role of behavioral factors in cancer etiology and prevention; survivorship studies; risk factors; implementation science and cancer care delivery; and the science of cancer health disparities. Besides welcoming manuscripts that address individual subjects in any of the relevant disciplines, CEBP editors encourage the submission of manuscripts with a transdisciplinary approach.
Journal title | Cancer Epidemiology Biomarkers and Prevention (CEBP) |
Abbreviation | Cancer Epidemiol Biomarkers Prev |
Print ISSN | 1055-9965 |
Online ISSN | 1538-7755 |
Publisher Name | American Association for Cancer Research |
Editor-in-chief | Elizabeth A. Platz |
Subject Category | Medicine |
Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Cancer Epidemiology Biomarkers and Prevention Journal is Cancer Epidemiol Biomarkers Prev.
The Ranking of the Journal in 2024 is 1410. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Journal's Impact Factor in 2024 is 3.8. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The Journal SCImago in 2024 is 1.923. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The Journal's H-Index in 2024 is 206. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
The Journal is indexed in (Indexing details)
PubMed | Scopus | Web of Science | UGC | Embase | DOAJ |
---|---|---|---|---|---|
✅ | ✅ | ✅ | ✅ | ❌ | ❌ |
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
Abbreviation | Cancer Epidemiol Biomarkers Prev |
Access type | Hybrid |
Impact Factor | 3.8 |
SJR | 1.923 |
SNIP | 1.230 |
Ranking | 1410 |
CiteScore | 6.5 |
H-Index | 206 |
Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of the Journal is $2300
Call for paper : The Journal invites original research contributions for consideration of publication in Cancer Epidemiology Biomarkers and Prevention journal.
Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.
for details about call for paper please visit to the official website of the journal to check the details about call for papers.
Publishing in Cancer Epidemiology Biomarkers and Prevention involves the following steps:
Yes, the journal is indexed in PubMed.
Yes, the journal is indexed in Scopus.
Yes, the journal is indexed in UGC.
No, the journal is not indexed in Index copernicus.
No, journal is not a predatory journal.
The Impact Factor of the Journal is 3.8.
The Ranking of the Journal is 1410.
Yes the journal is a peer-reviewed journal.
Yes the journal is a peer-reviewed journal and good to publish your paper.
Cancer Epidemiology Biomarkers and Prevention (CEBP) is a scholarly journal dedicated to publishing research in the field of Medicine. American Association for Cancer Research is the publisher of this esteemed journal.
Yes, Cancer Epidemiology Biomarkers and Prevention is a open access (Hybrid) journal.